Yibin City Commercial Bank Co., Ltd. Class H
Total Valuation
HKDAs of December 31, 2025, BrainAurora Medical Technology Limited carries a market capitalization of 8.75B, placing it among publicly traded companies globally. Its enterprise value stands at -1.07B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 8.75B |
| Enterprise Value | -1.07B |
Share Statistics
As of December 31, 2025, BrainAurora Medical Technology Limited has 1.36B shares outstanding.
| Shares Outstanding | 1.36B |
Valuation Ratios
These figures are as of December 31, 2025.
| PB Ratio | 0.70 |
| P/TBV Ratio | 0.70 |
Financial Position
These figures are as of December 31, 2025.
| Debt / Equity | 37.48 |
Financial Efficiency
These figures cover the twelve months ended December 31, 2025.
| Employee Count | 1,123.50 |
Stock Price Statistics
HKDAs of the close on October 22, 2026, BrainAurora Medical Technology Limited's stock has declined approximately 88.00% over the past 52 weeks. The 50-day moving average sits at 1.24, while the 200-day moving average is 3.09.
| 52-Week Price Change | -88.00% |
| 50-Day Moving Average | 1.24 |
| 200-Day Moving Average | 3.09 |
Balance Sheet
HKDAs of December 31, 2025, BrainAurora Medical Technology Limited holds 14.93B in cash and equivalents against 4.81B in total debt, resulting in a net debt position of -14.93B.
| Cash & Cash Equivalents | 14.93B |
| Total Debt | 4.81B |
| Net Debt | -14.93B |
| Equity (Book Value) | 12.54B |
| Book Value Per Share | 9.23 |